Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
54.32
-2.78 (-4.87%)
May 7, 2026, 9:31 AM EDT - Market open
Vaxcyte Employees
Vaxcyte had 507 employees as of December 31, 2025. The number of employees increased by 93 or 22.46% compared to the previous year.
Employees
507
Change (1Y)
93
Growth (1Y)
22.46%
Revenue / Employee
n/a
Profits / Employee
-$1,866,927
Market Cap
7.84B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 507 | 93 | 22.46% |
| Dec 31, 2024 | 414 | 160 | 62.99% |
| Dec 31, 2023 | 254 | 96 | 60.76% |
| Dec 31, 2022 | 158 | 69 | 77.53% |
| Dec 31, 2021 | 89 | 31 | 53.45% |
| Dec 31, 2020 | 58 | 15 | 34.88% |
| Dec 31, 2019 | 43 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Bio-Techne | 3,100 |
| ImmunityBio | 691 |
| Cytokinetics | 673 |
| Halozyme Therapeutics | 423 |
| Mirum Pharmaceuticals | 372 |
| Krystal Biotech | 295 |
| Kymera Therapeutics | 253 |
| Nuvalent | 228 |
PCVX News
- 17 hours ago - Vaxcyte Reports First Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 22 days ago - Vaxcyte Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 4 weeks ago - Vaxcyte to Present at the 25th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Vaxcyte Completes Enrollment of OPUS-1 and OPUS-2 Phase 3 Trials Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults - GlobeNewsWire
- 7 weeks ago - Positive VAX-31 Phase 1/2 Adult Data Published in The Lancet Infectious Diseases Highlight Best-in-Class Potential of Vaxcyte's 31-Valent Pneumococcal Conjugate Vaccine (PCV) Candidate - GlobeNewsWire
- 2 months ago - Vaxcyte Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Vaxcyte Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Vaxcyte Earnings Call Transcript: Q4 2025 - Transcripts